Evidence map›Paper›PMID 42370064›Full record

ArticleTransactions on machine learning research2026

Tumor-anchored deep feature random forests for out-of-distribution detection in lung cancer segmentation.

Aneesh Rangnekar, Harini Veeraraghavan

Abstract read
In one paragraph

Article in Transactions on machine learning research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aneesh RangnekarDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center.
Harini VeeraraghavanDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Safer lung cancer radiotherapy delivery using novel artificial intelligence methodsR01CA258821 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Harini Veeraraghavan · 2022 to 2026
$2.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA258821
6 · The paper itself

Abstract

Accurate segmentation of lung tumors from 3D computed tomography (CT) scans is essential for automated treatment planning and response assessment. Despite self-supervised pre-training on numerous datasets, state-of-the-art transformer backbones remain susceptible to out-of-distribution (OOD) inputs, often producing confidently incorrect segmentations with potential risk in clinical deployment. Hence, we introduce RF-Deep, a lightweight post-hoc random forests-based framework that uses deep features trained with limited outlier exposure, requiring as few as 40 labeled scans (20 in-distribution and 20 OOD), to improve scan-level OOD detection. RF-Deep repurposes the hierarchical features from the pretrained-then-finetuned segmentation backbones, aggregating features from multiple regions-of-interest anchored to predicted tumor regions to capture OOD likelihood. We evaluated RF-Deep on 2,232 CT volumes spanning near-OOD (pulmonary embolism, COVID-19 negative) and far-OOD (kidney cancer, healthy pancreas) datasets. RF-Deep achieved AUROC > 93 on the challenging near-OOD datasets, where it outperformed the next best method by 4-7 percentage points, and produced near-perfect detection (AUROC > 99) on far-OOD datasets. The approach also showed transferability to two blinded validation datasets under the ensemble configuration (COVID-19 positive and breast cancer; AUROC > 94). RF-Deep maintained consistent performance across backbones of different depths and pretraining strategies, demonstrating applicability of post-hoc detectors as a safety filter for clinical deployment of tumor segmentation pipelines.

Identifiers

PMID42370064
PMCPMC13298336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.